Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Most Moving TED Talks You Want to Watch - 2Recent studies prove the ancient practice of nasal irrigation is effective at fighting the common cold
- 3Catch the moon dancing with bright star Regulus tonight
- 4Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- 5Scientists uncover an ant assassination scheme that helps a parasitic queen rise to power
- 'The Beast in Me' arrives on Netflix: Is it based on a true story? And what drew Claire Danes to it? What to know about the thriller series.
- Nations for Youngsters to Visit
- Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
- 6 Novice Cameras for 2024: Ideal for New Picture takers
- Vote in favor of Your #1 4K television: Lucidity and Drenching Matter
- Teen drug use remains low, but survey finds small rise in heroin and cocaine use
- Unusual 'ingredients' helped stars form in a galaxy near the Milky Way
- Living Abroad: Social Inundation and Self-improvement
- Find the Advantages of Careful Eating: Developing a Sound Connection with Food
